0000859737-23-000011.txt : 20230502 0000859737-23-000011.hdr.sgml : 20230502 20230502075208 ACCESSION NUMBER: 0000859737-23-000011 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20230401 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOLOGIC INC CENTRAL INDEX KEY: 0000859737 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 042902449 STATE OF INCORPORATION: DE FISCAL YEAR END: 0928 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36214 FILM NUMBER: 23876654 BUSINESS ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: 5082632900 MAIL ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 10-Q 1 holx-20230401.htm 10-Q holx-20230401
false2023Q200008597379-28P3MP1YP1YP1YP1Y00008597372022-09-252023-04-0100008597372023-04-25xbrli:shares00008597372023-01-012023-04-01iso4217:USD00008597372021-12-262022-03-2600008597372021-09-262022-03-26iso4217:USDxbrli:shares00008597372023-04-0100008597372022-09-240000859737us-gaap:CommonStockMember2021-09-250000859737us-gaap:AdditionalPaidInCapitalMember2021-09-250000859737us-gaap:RetainedEarningsMember2021-09-250000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-250000859737us-gaap:TreasuryStockMember2021-09-2500008597372021-09-250000859737us-gaap:CommonStockMember2021-09-262021-12-250000859737us-gaap:AdditionalPaidInCapitalMember2021-09-262021-12-2500008597372021-09-262021-12-250000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-262021-12-250000859737us-gaap:TreasuryStockMember2021-09-262021-12-250000859737us-gaap:CommonStockMember2021-12-250000859737us-gaap:AdditionalPaidInCapitalMember2021-12-250000859737us-gaap:RetainedEarningsMember2021-12-250000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-250000859737us-gaap:TreasuryStockMember2021-12-2500008597372021-12-250000859737us-gaap:CommonStockMember2021-12-262022-03-260000859737us-gaap:AdditionalPaidInCapitalMember2021-12-262022-03-260000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-262022-03-260000859737us-gaap:TreasuryStockMember2021-12-262022-03-260000859737us-gaap:CommonStockMember2022-03-260000859737us-gaap:AdditionalPaidInCapitalMember2022-03-260000859737us-gaap:RetainedEarningsMember2022-03-260000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-260000859737us-gaap:TreasuryStockMember2022-03-2600008597372022-03-260000859737us-gaap:CommonStockMember2022-03-272022-06-250000859737us-gaap:AdditionalPaidInCapitalMember2022-03-272022-06-2500008597372022-03-272022-06-250000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-272022-06-250000859737us-gaap:CommonStockMember2022-06-250000859737us-gaap:AdditionalPaidInCapitalMember2022-06-250000859737us-gaap:RetainedEarningsMember2022-06-250000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-250000859737us-gaap:TreasuryStockMember2022-06-2500008597372022-06-250000859737us-gaap:CommonStockMember2022-06-262022-09-240000859737us-gaap:AdditionalPaidInCapitalMember2022-06-262022-09-2400008597372022-06-262022-09-240000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-262022-09-240000859737us-gaap:TreasuryStockMember2022-06-262022-09-240000859737us-gaap:CommonStockMember2022-09-240000859737us-gaap:AdditionalPaidInCapitalMember2022-09-240000859737us-gaap:RetainedEarningsMember2022-09-240000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-240000859737us-gaap:TreasuryStockMember2022-09-240000859737us-gaap:CommonStockMember2022-09-252022-12-310000859737us-gaap:AdditionalPaidInCapitalMember2022-09-252022-12-3100008597372022-09-252022-12-310000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-252022-12-310000859737us-gaap:TreasuryStockMember2022-09-252022-12-310000859737us-gaap:CommonStockMember2022-12-310000859737us-gaap:AdditionalPaidInCapitalMember2022-12-310000859737us-gaap:RetainedEarningsMember2022-12-310000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000859737us-gaap:TreasuryStockMember2022-12-3100008597372022-12-310000859737us-gaap:CommonStockMember2023-01-012023-04-010000859737us-gaap:AdditionalPaidInCapitalMember2023-01-012023-04-010000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-04-010000859737us-gaap:TreasuryStockMember2023-01-012023-04-010000859737us-gaap:CommonStockMember2023-04-010000859737us-gaap:AdditionalPaidInCapitalMember2023-04-010000859737us-gaap:RetainedEarningsMember2023-04-010000859737us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-010000859737us-gaap:TreasuryStockMember2023-04-010000859737holx:CytologyPerinatalMembercountry:USholx:DiagnosticsMember2023-01-012023-04-010000859737holx:InternationalMemberholx:CytologyPerinatalMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:CytologyPerinatalMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:CytologyPerinatalMembercountry:USholx:DiagnosticsMember2021-12-262022-03-260000859737holx:InternationalMemberholx:CytologyPerinatalMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:CytologyPerinatalMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:MolecularDiagnosticsMembercountry:USholx:DiagnosticsMember2023-01-012023-04-010000859737holx:InternationalMemberholx:MolecularDiagnosticsMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:MolecularDiagnosticsMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:MolecularDiagnosticsMembercountry:USholx:DiagnosticsMember2021-12-262022-03-260000859737holx:InternationalMemberholx:MolecularDiagnosticsMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:MolecularDiagnosticsMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:BloodScreeningMembercountry:USholx:DiagnosticsMember2023-01-012023-04-010000859737holx:InternationalMemberholx:BloodScreeningMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:BloodScreeningMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:BloodScreeningMembercountry:USholx:DiagnosticsMember2021-12-262022-03-260000859737holx:InternationalMemberholx:BloodScreeningMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:BloodScreeningMemberholx:DiagnosticsMember2021-12-262022-03-260000859737country:USholx:DiagnosticsMember2023-01-012023-04-010000859737holx:InternationalMemberholx:DiagnosticsMember2023-01-012023-04-010000859737holx:DiagnosticsMember2023-01-012023-04-010000859737country:USholx:DiagnosticsMember2021-12-262022-03-260000859737holx:InternationalMemberholx:DiagnosticsMember2021-12-262022-03-260000859737holx:DiagnosticsMember2021-12-262022-03-260000859737holx:BreastHealthMembercountry:USholx:BreastImagingMember2023-01-012023-04-010000859737holx:BreastHealthMemberholx:InternationalMemberholx:BreastImagingMember2023-01-012023-04-010000859737holx:BreastHealthMemberholx:BreastImagingMember2023-01-012023-04-010000859737holx:BreastHealthMembercountry:USholx:BreastImagingMember2021-12-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMemberholx:BreastImagingMember2021-12-262022-03-260000859737holx:BreastHealthMemberholx:BreastImagingMember2021-12-262022-03-260000859737holx:BreastHealthMembercountry:USholx:InterventionalBreastSolutionsMember2023-01-012023-04-010000859737holx:BreastHealthMemberholx:InternationalMemberholx:InterventionalBreastSolutionsMember2023-01-012023-04-010000859737holx:BreastHealthMemberholx:InterventionalBreastSolutionsMember2023-01-012023-04-010000859737holx:BreastHealthMembercountry:USholx:InterventionalBreastSolutionsMember2021-12-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMemberholx:InterventionalBreastSolutionsMember2021-12-262022-03-260000859737holx:BreastHealthMemberholx:InterventionalBreastSolutionsMember2021-12-262022-03-260000859737holx:BreastHealthMembercountry:US2023-01-012023-04-010000859737holx:BreastHealthMemberholx:InternationalMember2023-01-012023-04-010000859737holx:BreastHealthMember2023-01-012023-04-010000859737holx:BreastHealthMembercountry:US2021-12-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMember2021-12-262022-03-260000859737holx:BreastHealthMember2021-12-262022-03-260000859737holx:GynSurgicalMembercountry:US2023-01-012023-04-010000859737holx:InternationalMemberholx:GynSurgicalMember2023-01-012023-04-010000859737holx:GynSurgicalMember2023-01-012023-04-010000859737holx:GynSurgicalMembercountry:US2021-12-262022-03-260000859737holx:InternationalMemberholx:GynSurgicalMember2021-12-262022-03-260000859737holx:GynSurgicalMember2021-12-262022-03-260000859737holx:SkeletalHealthMembercountry:US2023-01-012023-04-010000859737holx:InternationalMemberholx:SkeletalHealthMember2023-01-012023-04-010000859737holx:SkeletalHealthMember2023-01-012023-04-010000859737holx:SkeletalHealthMembercountry:US2021-12-262022-03-260000859737holx:InternationalMemberholx:SkeletalHealthMember2021-12-262022-03-260000859737holx:SkeletalHealthMember2021-12-262022-03-260000859737country:US2023-01-012023-04-010000859737holx:InternationalMember2023-01-012023-04-010000859737country:US2021-12-262022-03-260000859737holx:InternationalMember2021-12-262022-03-260000859737holx:CytologyPerinatalMembercountry:USholx:DiagnosticsMember2022-09-252023-04-010000859737holx:InternationalMemberholx:CytologyPerinatalMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:CytologyPerinatalMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:CytologyPerinatalMembercountry:USholx:DiagnosticsMember2021-09-262022-03-260000859737holx:InternationalMemberholx:CytologyPerinatalMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:CytologyPerinatalMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:MolecularDiagnosticsMembercountry:USholx:DiagnosticsMember2022-09-252023-04-010000859737holx:InternationalMemberholx:MolecularDiagnosticsMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:MolecularDiagnosticsMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:MolecularDiagnosticsMembercountry:USholx:DiagnosticsMember2021-09-262022-03-260000859737holx:InternationalMemberholx:MolecularDiagnosticsMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:MolecularDiagnosticsMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:BloodScreeningMembercountry:USholx:DiagnosticsMember2022-09-252023-04-010000859737holx:InternationalMemberholx:BloodScreeningMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:BloodScreeningMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:BloodScreeningMembercountry:USholx:DiagnosticsMember2021-09-262022-03-260000859737holx:InternationalMemberholx:BloodScreeningMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:BloodScreeningMemberholx:DiagnosticsMember2021-09-262022-03-260000859737country:USholx:DiagnosticsMember2022-09-252023-04-010000859737holx:InternationalMemberholx:DiagnosticsMember2022-09-252023-04-010000859737holx:DiagnosticsMember2022-09-252023-04-010000859737country:USholx:DiagnosticsMember2021-09-262022-03-260000859737holx:InternationalMemberholx:DiagnosticsMember2021-09-262022-03-260000859737holx:DiagnosticsMember2021-09-262022-03-260000859737holx:BreastHealthMembercountry:USholx:BreastImagingMember2022-09-252023-04-010000859737holx:BreastHealthMemberholx:InternationalMemberholx:BreastImagingMember2022-09-252023-04-010000859737holx:BreastHealthMemberholx:BreastImagingMember2022-09-252023-04-010000859737holx:BreastHealthMembercountry:USholx:BreastImagingMember2021-09-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMemberholx:BreastImagingMember2021-09-262022-03-260000859737holx:BreastHealthMemberholx:BreastImagingMember2021-09-262022-03-260000859737holx:BreastHealthMembercountry:USholx:InterventionalBreastSolutionsMember2022-09-252023-04-010000859737holx:BreastHealthMemberholx:InternationalMemberholx:InterventionalBreastSolutionsMember2022-09-252023-04-010000859737holx:BreastHealthMemberholx:InterventionalBreastSolutionsMember2022-09-252023-04-010000859737holx:BreastHealthMembercountry:USholx:InterventionalBreastSolutionsMember2021-09-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMemberholx:InterventionalBreastSolutionsMember2021-09-262022-03-260000859737holx:BreastHealthMemberholx:InterventionalBreastSolutionsMember2021-09-262022-03-260000859737holx:BreastHealthMembercountry:US2022-09-252023-04-010000859737holx:BreastHealthMemberholx:InternationalMember2022-09-252023-04-010000859737holx:BreastHealthMember2022-09-252023-04-010000859737holx:BreastHealthMembercountry:US2021-09-262022-03-260000859737holx:BreastHealthMemberholx:InternationalMember2021-09-262022-03-260000859737holx:BreastHealthMember2021-09-262022-03-260000859737holx:GynSurgicalMembercountry:US2022-09-252023-04-010000859737holx:InternationalMemberholx:GynSurgicalMember2022-09-252023-04-010000859737holx:GynSurgicalMember2022-09-252023-04-010000859737holx:GynSurgicalMembercountry:US2021-09-262022-03-260000859737holx:InternationalMemberholx:GynSurgicalMember2021-09-262022-03-260000859737holx:GynSurgicalMember2021-09-262022-03-260000859737holx:SkeletalHealthMembercountry:US2022-09-252023-04-010000859737holx:InternationalMemberholx:SkeletalHealthMember2022-09-252023-04-010000859737holx:SkeletalHealthMember2022-09-252023-04-010000859737holx:SkeletalHealthMembercountry:US2021-09-262022-03-260000859737holx:InternationalMemberholx:SkeletalHealthMember2021-09-262022-03-260000859737holx:SkeletalHealthMember2021-09-262022-03-260000859737country:US2022-09-252023-04-010000859737holx:InternationalMember2022-09-252023-04-010000859737country:US2021-09-262022-03-260000859737holx:InternationalMember2021-09-262022-03-260000859737srt:EuropeMember2023-01-012023-04-010000859737srt:EuropeMember2021-12-262022-03-260000859737srt:EuropeMember2022-09-252023-04-010000859737srt:EuropeMember2021-09-262022-03-260000859737srt:AsiaPacificMember2023-01-012023-04-010000859737srt:AsiaPacificMember2021-12-262022-03-260000859737srt:AsiaPacificMember2022-09-252023-04-010000859737srt:AsiaPacificMember2021-09-262022-03-260000859737holx:RestofWorldMember2023-01-012023-04-010000859737holx:RestofWorldMember2021-12-262022-03-260000859737holx:RestofWorldMember2022-09-252023-04-010000859737holx:RestofWorldMember2021-09-262022-03-260000859737holx:ConsumablesMember2023-01-012023-04-010000859737holx:ConsumablesMember2021-12-262022-03-260000859737holx:ConsumablesMember2022-09-252023-04-010000859737holx:ConsumablesMember2021-09-262022-03-260000859737holx:CapitalEquipmentComponentsandSoftwareMember2023-01-012023-04-010000859737holx:CapitalEquipmentComponentsandSoftwareMember2021-12-262022-03-260000859737holx:CapitalEquipmentComponentsandSoftwareMember2022-09-252023-04-010000859737holx:CapitalEquipmentComponentsandSoftwareMember2021-09-262022-03-260000859737us-gaap:ServiceMember2023-01-012023-04-010000859737us-gaap:ServiceMember2021-12-262022-03-260000859737us-gaap:ServiceMember2022-09-252023-04-010000859737us-gaap:ServiceMember2021-09-262022-03-260000859737holx:OtherTypeofRevenueMember2023-01-012023-04-010000859737holx:OtherTypeofRevenueMember2021-12-262022-03-260000859737holx:OtherTypeofRevenueMember2022-09-252023-04-010000859737holx:OtherTypeofRevenueMember2021-09-262022-03-2600008597372023-03-292023-04-01xbrli:pure00008597372024-03-292023-04-0100008597372025-03-292023-04-0100008597372026-03-292023-04-0100008597372027-03-292023-04-010000859737us-gaap:InterestRateSwapMember2023-04-010000859737us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2023-04-010000859737us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2023-04-010000859737us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2023-04-010000859737us-gaap:ForeignExchangeContractMember2023-04-010000859737us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMember2023-04-010000859737us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2023-04-010000859737us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMember2023-04-010000859737us-gaap:ForeignExchangeOptionMember2023-04-010000859737us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeOptionMember2023-04-010000859737us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeOptionMember2023-04-010000859737us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeOptionMember2023-04-010000859737us-gaap:FairValueInputsLevel1Member2023-04-010000859737us-gaap:FairValueInputsLevel2Member2023-04-010000859737us-gaap:FairValueInputsLevel3Member2023-04-010000859737holx:ContingentConsiderationMember2023-04-010000859737holx:ContingentConsiderationMemberus-gaap:FairValueInputsLevel1Member2023-04-010000859737holx:ContingentConsiderationMemberus-gaap:FairValueInputsLevel2Member2023-04-010000859737holx:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Member2023-04-010000859737us-gaap:EquityMethodInvestmentsMember2021-12-262022-03-260000859737holx:CreditAgreementMember2023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028SeniorNotesMember2023-04-010000859737us-gaap:SeniorNotesMemberholx:A2029SeniorNotesMember2023-04-010000859737holx:A2028SeniorNotesMember2023-04-010000859737holx:A2029SeniorNotesMember2023-04-010000859737holx:BolderSurgicalMember2021-11-292021-11-290000859737holx:BolderSurgicalMember2021-11-290000859737holx:DevelopedTechnologyMemberholx:BolderSurgicalMember2021-11-292021-11-290000859737us-gaap:TradeNamesMemberholx:BolderSurgicalMember2021-11-292021-11-290000859737us-gaap:CustomerRelationshipsMemberholx:BolderSurgicalMember2021-11-292021-11-290000859737holx:AcessaHealthMember2020-08-230000859737holx:AcessaHealthMember2020-08-232020-08-230000859737holx:AcessaHealthMember2021-09-262022-09-240000859737holx:AcessaHealthMember2021-09-262021-12-250000859737holx:AcessaHealthMember2021-12-262022-03-260000859737holx:AcessaHealthMember2023-01-012023-04-010000859737holx:AcessaHealthMember2023-04-010000859737holx:DanburyClosureMember2023-01-012023-04-010000859737holx:DanburyClosureMember2022-09-252023-04-010000859737holx:DanburyClosureMember2021-09-262022-03-260000859737holx:DanburyClosureMember2023-04-010000859737holx:GermanyPlanMember2023-01-012023-04-010000859737holx:GermanyPlanMember2022-09-252023-04-010000859737holx:GermanyPlanMember2023-04-010000859737holx:TermLoanMember2023-04-010000859737holx:TermLoanMember2022-09-240000859737holx:A2028SeniorNotesMember2023-04-010000859737holx:A2028SeniorNotesMember2022-09-240000859737holx:A2029SeniorNotesMember2023-04-010000859737holx:A2029SeniorNotesMember2022-09-240000859737holx:SecuredTermLoanMemberholx:A2021TermLoanMember2021-09-270000859737holx:RevolverMemberholx:A2021RevolverMember2021-09-270000859737holx:SecuredTermLoanMemberholx:A2021TermLoanMember2023-04-010000859737holx:A2021CreditAgreementMemberholx:TermLoanMember2023-01-012023-04-010000859737holx:A2021CreditAgreementMemberholx:TermLoanMember2023-04-010000859737holx:CreditAgreementMember2023-01-012023-04-010000859737holx:CreditAgreementMember2021-12-262022-03-260000859737holx:CreditAgreementMember2022-09-252023-04-010000859737holx:CreditAgreementMember2021-09-262022-03-260000859737holx:CreditAgreementMember2022-03-260000859737us-gaap:InterestRateSwapMember2023-04-010000859737us-gaap:InterestRateSwapMember2023-01-012023-04-010000859737us-gaap:InterestRateSwapMember2022-09-252023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028SeniorNotesMember2023-01-012023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028SeniorNotesMember2021-12-262022-03-260000859737us-gaap:SeniorNotesMemberholx:A2028SeniorNotesMember2022-09-252023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028SeniorNotesMember2021-09-262022-03-260000859737us-gaap:SeniorNotesMemberholx:A2029SeniorNotesMember2023-01-012023-04-010000859737us-gaap:SeniorNotesMemberholx:A2029SeniorNotesMember2021-12-262022-03-260000859737us-gaap:SeniorNotesMemberholx:A2029SeniorNotesMember2022-09-252023-04-010000859737us-gaap:SeniorNotesMemberholx:A2029SeniorNotesMember2021-09-262022-03-260000859737us-gaap:SeniorNotesMemberholx:A2028And2029SeniorNotesMember2023-01-012023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028And2029SeniorNotesMember2021-12-262022-03-260000859737us-gaap:SeniorNotesMemberholx:A2028And2029SeniorNotesMember2022-09-252023-04-010000859737us-gaap:SeniorNotesMemberholx:A2028And2029SeniorNotesMember2021-09-262022-03-260000859737holx:AssetSecuritizationMember2022-04-012022-04-300000859737us-gaap:InterestRateSwapMember2022-09-240000859737holx:InterestRateSwap2024Member2023-03-230000859737holx:InterestRateSwap2023Member2023-03-230000859737holx:InterestRateSwap2023Member2023-04-010000859737holx:InterestRateSwap2024Member2023-04-010000859737us-gaap:ForwardContractsMember2023-04-010000859737us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2023-01-012023-04-010000859737us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-12-262022-03-260000859737us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-09-252023-04-010000859737us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-09-262022-03-260000859737us-gaap:ForeignExchangeOptionMemberus-gaap:NondesignatedMember2023-01-012023-04-010000859737us-gaap:ForeignExchangeOptionMemberus-gaap:NondesignatedMember2021-12-262022-03-260000859737us-gaap:ForeignExchangeOptionMemberus-gaap:NondesignatedMember2022-09-252023-04-010000859737us-gaap:ForeignExchangeOptionMemberus-gaap:NondesignatedMember2021-09-262022-03-260000859737us-gaap:NondesignatedMember2023-01-012023-04-010000859737us-gaap:NondesignatedMember2021-12-262022-03-260000859737us-gaap:NondesignatedMember2022-09-252023-04-010000859737us-gaap:NondesignatedMember2021-09-262022-03-260000859737us-gaap:InterestRateCapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-04-010000859737us-gaap:InterestRateCapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-09-240000859737us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMember2023-04-010000859737us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMember2022-09-240000859737us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-04-010000859737us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-09-240000859737us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-04-010000859737us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-09-240000859737us-gaap:ForeignExchangeOptionMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-04-010000859737us-gaap:ForeignExchangeOptionMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-09-240000859737us-gaap:NondesignatedMember2023-04-010000859737us-gaap:NondesignatedMember2022-09-240000859737us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2023-04-010000859737us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2022-09-240000859737us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2023-04-010000859737us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2022-09-240000859737us-gaap:InterestRateSwapMember2021-12-262022-03-260000859737us-gaap:InterestRateSwapMember2021-09-262022-03-260000859737holx:MinervaMember2018-07-270000859737holx:MinervaMember2016-03-042016-03-04holx:petition0000859737holx:MinervaMember2023-01-012023-04-010000859737us-gaap:StockCompensationPlanMember2023-01-012023-04-010000859737us-gaap:StockCompensationPlanMember2021-12-262022-03-260000859737us-gaap:StockCompensationPlanMember2022-09-252023-04-010000859737us-gaap:StockCompensationPlanMember2021-09-262022-03-260000859737us-gaap:CostOfSalesMember2023-01-012023-04-010000859737us-gaap:CostOfSalesMember2021-12-262022-03-260000859737us-gaap:CostOfSalesMember2022-09-252023-04-010000859737us-gaap:CostOfSalesMember2021-09-262022-03-260000859737us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-04-010000859737us-gaap:ResearchAndDevelopmentExpenseMember2021-12-262022-03-260000859737us-gaap:ResearchAndDevelopmentExpenseMember2022-09-252023-04-010000859737us-gaap:ResearchAndDevelopmentExpenseMember2021-09-262022-03-260000859737us-gaap:SellingAndMarketingExpenseMember2023-01-012023-04-010000859737us-gaap:SellingAndMarketingExpenseMember2021-12-262022-03-260000859737us-gaap:SellingAndMarketingExpenseMember2022-09-252023-04-010000859737us-gaap:SellingAndMarketingExpenseMember2021-09-262022-03-260000859737us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-04-010000859737us-gaap:GeneralAndAdministrativeExpenseMember2021-12-262022-03-260000859737us-gaap:GeneralAndAdministrativeExpenseMember2022-09-252023-04-010000859737us-gaap:GeneralAndAdministrativeExpenseMember2021-09-262022-03-260000859737us-gaap:EmployeeStockOptionMember2022-09-252023-04-010000859737us-gaap:EmployeeStockOptionMember2021-09-262022-03-260000859737us-gaap:EmployeeStockOptionMember2023-04-010000859737us-gaap:RestrictedStockUnitsRSUMember2022-09-252023-04-010000859737us-gaap:RestrictedStockUnitsRSUMember2021-09-262022-03-260000859737us-gaap:PerformanceSharesMember2022-09-252023-04-010000859737us-gaap:PerformanceSharesMember2021-09-262022-03-260000859737holx:MarketBasedAwardsMember2022-09-252023-04-010000859737holx:PSUFreeCashFlowMember2022-09-252023-04-010000859737holx:PSUFreeCashFlowMember2021-09-262022-03-260000859737holx:MarketBasedAwardsMember2021-09-262022-03-260000859737holx:RSUPSUMSUMember2023-04-010000859737us-gaap:RestrictedStockUnitsRSUMember2023-04-0100008597372020-06-282020-09-2600008597372020-09-272020-12-26holx:Segment0000859737us-gaap:IntersegmentEliminationMember2023-01-012023-04-010000859737us-gaap:IntersegmentEliminationMember2021-12-262022-03-260000859737us-gaap:IntersegmentEliminationMember2021-09-262022-03-260000859737us-gaap:IntersegmentEliminationMember2022-09-252023-04-010000859737us-gaap:CorporateMember2023-01-012023-04-010000859737us-gaap:CorporateMember2021-12-262022-03-260000859737us-gaap:CorporateMember2022-09-252023-04-010000859737us-gaap:CorporateMember2021-09-262022-03-260000859737holx:DiagnosticsMember2023-04-010000859737holx:DiagnosticsMember2022-09-240000859737holx:BreastHealthMember2023-04-010000859737holx:BreastHealthMember2022-09-240000859737holx:GynSurgicalMember2023-04-010000859737holx:GynSurgicalMember2022-09-240000859737holx:SkeletalHealthMember2023-04-010000859737holx:SkeletalHealthMember2022-09-240000859737us-gaap:CorporateMember2023-04-010000859737us-gaap:CorporateMember2022-09-240000859737holx:AllOtherCountriesMember2023-01-012023-04-010000859737holx:AllOtherCountriesMember2021-12-262022-03-260000859737holx:AllOtherCountriesMember2022-09-252023-04-010000859737holx:AllOtherCountriesMember2021-09-262022-03-260000859737holx:DevelopedTechnologyMember2023-04-010000859737holx:DevelopedTechnologyMember2022-09-240000859737us-gaap:InProcessResearchAndDevelopmentMember2023-04-010000859737us-gaap:InProcessResearchAndDevelopmentMember2022-09-240000859737holx:CustomerRelationshipsContractsMember2023-04-010000859737holx:CustomerRelationshipsContractsMember2022-09-240000859737us-gaap:TradeNamesMember2023-04-010000859737us-gaap:TradeNamesMember2022-09-240000859737holx:AcquiredintangibleassetsMember2023-04-010000859737holx:AcquiredintangibleassetsMember2022-09-240000859737holx:InternalusesoftwareMember2023-04-010000859737holx:InternalusesoftwareMember2022-09-240000859737holx:CapitalizedsoftwareMember2023-04-010000859737holx:CapitalizedsoftwareMember2022-09-240000859737us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000859737us-gaap:AccumulatedTranslationAdjustmentMember2022-09-240000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-240000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-240000859737us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-04-010000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-04-010000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-04-010000859737us-gaap:AccumulatedTranslationAdjustmentMember2022-09-252023-04-010000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-252023-04-010000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-252023-04-010000859737us-gaap:AccumulatedTranslationAdjustmentMember2023-04-010000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-010000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-010000859737us-gaap:AccumulatedTranslationAdjustmentMember2021-12-250000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-250000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-250000859737us-gaap:AccumulatedTranslationAdjustmentMember2021-09-250000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-250000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-09-250000859737us-gaap:AccumulatedTranslationAdjustmentMember2021-12-262022-03-260000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-262022-03-260000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-262022-03-260000859737us-gaap:AccumulatedTranslationAdjustmentMember2021-09-262022-03-260000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-262022-03-260000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-09-262022-03-260000859737us-gaap:AccumulatedTranslationAdjustmentMember2022-03-260000859737us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-260000859737us-gaap:InterestRateSwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-260000859737holx:September222022Member2023-04-010000859737holx:December112020Member2023-04-010000859737holx:September222022Member2023-01-012023-04-010000859737holx:September222022Member2022-09-252023-04-01


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
__________________________________________________________ 
FORM 10-Q
 
 __________________________________________________________ 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2023
or 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 1-36214
__________________________________________________________ 
HOLOGIC, INC.
(Exact name of registrant as specified in its charter)
 __________________________________________________________
Delaware 04-2902449
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
250 Campus Drive, 
Marlborough,
Massachusetts
01752
(Address of principal executive offices) (Zip Code)
(508) 263-2900
(Registrant’s telephone number, including area code)
 __________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueHOLXNASDAQ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer   Accelerated filer 
Non-accelerated filer 
  Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  
As of April 25, 2023, 246,118,192 shares of the registrant’s Common Stock, $0.01 par value, were outstanding.


HOLOGIC, INC.
INDEX
 
 Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 6.
EXHIBITS

2

PART I – FINANCIAL INFORMATION
 
Item 1.    Financial Statements (unaudited)
HOLOGIC, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

(In millions, except number of shares, which are reflected in thousands, and per share data)
 Three Months EndedSix Months Ended
 April 1,
2023
March 26,
2022
April 1,
2023
March 26,
2022
Revenues:
Product$837.4 $1,268.2 $1,723.8 $2,571.6 
Service and other189.1 167.5 376.9 335.3 
1,026.5 1,435.7 2,100.7 2,906.9 
Costs of revenues:
Product292.1 322.6 588.3 640.7 
Amortization of acquired intangible assets52.1 72.3 107.7 147.2 
Service and other96.5 94.2 201.0 186.1 
Gross profit585.8 946.6 1,203.7 1,932.9 
Operating expenses:
Research and development74.0 69.5 148.8 142.3 
Selling and marketing142.4 171.4 305.9 318.7 
General and administrative100.8 100.5 209.3 218.5 
Amortization of acquired intangible assets7.1 11.3 14.7 22.1 
Contingent consideration - fair value adjustments(12.4) (12.4)(4.1)
Restructuring charges1.8 (0.2)2.9  
313.7 352.5 669.2 697.5 
Income from operations272.1 594.1 534.5 1,235.4 
Interest income31.5 0.8 52.1 1.2 
Interest expense(27.2)(22.6)(55.3)(48.3)
Debt extinguishment loss   (0.7)
Other income (expense), net2.9 2.1 (12.9)8.7 
Income before income taxes279.3 574.4 518.4 1,196.3 
Provision for income taxes60.8 118.7 112.5 241.4 
Net income$218.5 $455.7 $405.9 $954.9 
Net income per common share:
Basic$0.88 $1.81 $1.64 $3.78 
Diluted$0.87 $1.80 $1.63 $3.75 
Weighted average number of shares outstanding:
Basic247,730 251,574 247,524 252,537 
Diluted249,793 253,658 249,537 254,864 
See accompanying notes.
3

HOLOGIC, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
(In millions)
 Three Months EndedSix Months Ended
 April 1,
2023
March 26,
2022
April 1,
2023
March 26,
2022
Net income$218.5 $455.7 $405.9 $954.9 
Changes in foreign currency translation adjustment15.3 (34.5)129.1 (72.3)
Changes in value of hedged interest rate swaps, net of tax of $(2.0) and $(2.9) for the three and six months ended April 1, 2023 and $6.5 and $9.1 for the three and six months ended March 26, 2022.
Gain (loss) recognized in other comprehensive income (loss), net(6.4)19.4 (9.3)27.3 
Other comprehensive income (loss)8.9 (15.1)119.8 (45.0)
Comprehensive income$227.4 $440.6 $525.7 $909.9 
See accompanying notes.


4

HOLOGIC, INC.

CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In millions, except number of shares, which are reflected in thousands, and par value)
 
April 1,
2023
September 24,
2022
ASSETS
Current assets:
Cash and cash equivalents$2,582.2 $2,339.5 
Accounts receivable, less reserves714.0 617.6 
Inventories687.6 623.7 
Prepaid expenses and other current assets187.0 232.2 
Prepaid income taxes40.6 49.0 
Total current assets4,211.4 3,862.0 
Property, plant and equipment, net497.9 481.6 
Intangible assets, net1,202.2 1,280.6 
Goodwill3,296.9 3,236.5 
Other assets240.3 210.5 
Total assets$9,448.7 $9,071.2 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt$26.2 $15.0 
Accounts payable187.4 197.7 
Accrued expenses508.0 535.3 
Deferred revenue230.5 186.5 
Finance lease obligations2.9 3.2 
Total current liabilities955.0 937.7 
Long-term debt, net of current portion2,797.7 2,808.4 
Finance lease obligations, net of current portion17.0 18.0 
Deferred income tax liabilities33.4 90.8 
Deferred revenue, net of current portion12.8 9.4 
Other long-term liabilities332.0 330.7 
Stockholders’ equity:
Preferred stock, $0.01 par value – 1,623 shares authorized; 0 shares issued
  
Common stock, $0.01 par value – 750,000 shares authorized; 299,676 and 298,533 shares issued, respectively
3.0 3.0 
Additional paid-in-capital6,091.5 6,042.6 
Retained earnings2,006.2 1,600.3 
Treasury stock, at cost – 53,566 and 51,401 shares, respectively
(2,681.5)(2,531.5)
Accumulated other comprehensive loss(118.4)(238.2)
Total stockholders’ equity5,300.8 4,876.2 
Total liabilities and stockholders’ equity$9,448.7 $9,071.2 
See accompanying notes.
5

Hologic, Inc.
Consolidated Statements of Stockholders’ Equity
(In millions, except number of shares, which are reflected in thousands)
 Common StockAdditional
Paid-in-
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Treasury StockTotal
Stockholders’
Equity
 Number of
Shares
Par ValueNumber of
Shares
Amount
Balance at September 25, 2021297,306 $3.0 $5,965.8 $298.3 $(59.1)43,653 $(1,989.4)$4,218.6 
Exercise of stock options45 — 1.9 — — — — 1.9 
Vesting of restricted stock units, net534 — (22.4)— — — — (22.4)
Stock-based compensation— — 18.7 — — — — 18.7 
Net income— — — 499.2 — — — 499.2 
Other comprehensive income activity— — — — (29.9)— — (29.9)
Repurchase of common stock— — — — — 2,335 (167.0)(167.0)
Balance at December 25, 2021297,885 $3.0 $5,964.0 $797.5 $(89.0)45,988 $(2,156.4)$4,519.1 
Exercise of stock options140 — 5.8 — — — — 5.8 
Vesting of restricted stock units, net14 — (0.1)— — — — (0.1)
Common stock issued under the employee stock purchase plan164 — 9.5 — — — — 9.5 
Stock-based compensation— — 17.8 — — — — 17.8 
Net income— — — 455.7 — — — 455.7 
Other comprehensive income activity— — — — (15.1)— — (15.1)
Repurchase of common stock— — — — — 2,863 (200.0)(200.0)
Balance at March 26, 2022298,203 $3.0 $5,997.0 $1,253.2 $(104.1)48,851 $(2,356.4)$4,792.7 
Exercise of stock options128 — 5.2 — — — — 5.2 
Vesting of restricted stock units, net4 — (0.1)— — — — (0.1)
Stock-based compensation— — 15.3 — — — — 15.3 
Net income— — — 228.4 — — — 228.4 
Other comprehensive income activity— — — — (43.6)— — (43.6)
Balance at June 25, 2022298,335 $3.0 $6,017.4 $1,481.6 $(147.7)48,851 $(2,356.4)$4,997.9 
Exercise of stock options23 — 0.9 — — — — 0.9 
Vesting of restricted stock units, net9 — (0.3)— — — — (0.3)
Common stock issued under the employee stock purchase plan166 — 9.7 — — — — 9.7 
Stock-based compensation— — 14.9 — — — — 14.9 
Net income— — — 118.7 — — — 118.7 
Other comprehensive income activity— — — — (90.5)— — (90.5)
Repurchase of common stock— — — — — 2,550 $(175.1)(175.1)
Balance at September 24, 2022298,533 $3.0 $6,042.6 $1,600.3 $(238.2)51,401 $(2,531.5)$4,876.2 
Exercise of stock options267 — 10.3 — — — — 10.3 
Vesting of restricted stock units, net514 — (23.0)— — — — (23.0)
Common stock issued under the employee stock purchase plan171 — 10.2 — — — — 10.2 
Stock-based compensation— — 20.5 — — — — 20.5 
Net income— — — 187.4 — — — 187.4 
Other comprehensive income activity— — — — 110.9 — — 110.9 
Repurchase of common stock— — — — — 1,539 (100.0)(100.0)
Balance at December 31, 2022299,485 $3.0 $6,060.6 $1,787.7 $(127.3)52,940 $(2,631.5)$5,092.5 
6

Exercise of stock options173 — 7.9 — — — — 7.9 
Vesting of restricted stock units, net18 — (0.2)— — — — (0.2)
Stock-based compensation— — 23.2 — — — — 23.2 
Net income— — — 218.5 — — — 218.5 
Other comprehensive income activity— — — — 8.9 — — 8.9 
Repurchase of common stock— — — — — 626 (50.0)(50.0)
Balance at April 1, 2023299,676 $3.0 $6,091.5 $2,006.2 $(118.4)53,566 $(2,681.5)$5,300.8 

7

HOLOGIC, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In millions)
Six Months Ended
 April 1,
2023
March 26,
2022
OPERATING ACTIVITIES
Net income $405.9 $954.9 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation44.3 44.9 
Amortization of acquired intangible assets122.4 169.2 
Stock-based compensation expense43.7 36.5 
Deferred income taxes(61.6)(41.5)
Contingent consideration - fair value adjustments(12.4)(4.1)
Other adjustments and non-cash items29.6 23.5 
Changes in operating assets and liabilities, excluding the effect of acquisitions:
Accounts receivable(81.8)101.6 
Inventories(56.1)(26.4)
Prepaid income taxes8.3 (6.4)
Prepaid expenses and other assets10.5 355.3 
Accounts payable(13.2)9.1 
Accrued expenses and other liabilities(22.4)2.9 
Deferred revenue42.5 6.9 
Net cash provided by operating activities459.7 1,626.4 
INVESTING ACTIVITIES
Acquisition of business, net of cash acquired (158.4)
Capital expenditures(34.5)(36.1)
Proceeds from the Department of Defense20.5 58.7 
Increase in equipment under customer usage agreements(26.7)(33.8)
Purchase of equity investment(10.0) 
Other activity(6.7)5.2 
Net cash used in investing activities(57.4)(164.4)
FINANCING ACTIVITIES
Proceeds from long-term debt, net of issuance costs 1,491.2 
Repayment of long-term debt(7.5)(1,387.5)
Payment of contingent consideration(7.6)(12.2)
Payment of deferred acquisition consideration(0.8) 
Repayment of acquired long-term debt (63.6)
Repurchases of common stock(150.0)(367.0)
Proceeds from issuance of common stock pursuant to employee stock plans28.4 17.3 
Payment of minimum tax withholdings on net share settlements of equity awards(23.2)(22.5)
Payments under finance lease obligations(2.3)(1.7)
Net cash used in financing activities(163.0)(346.0)
Effect of exchange rate changes on cash and cash equivalents3.4 4.5 
Net increase in cash and cash equivalents242.7